MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Luventa XL 16mg capsules (Fontus Health Ltd)

Explore other Galantamine formulations Explore other Galantamine 16mg modified-release capsules suppliers

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 16mg capsules (Krka UK Ltd) and Reminyl XL 16mg capsules (Takeda UK Ltd).

Use with caution

Luventa XL 24mg capsules (Fontus Health Ltd)

Explore other Galantamine formulations Explore other Galantamine 24mg modified-release capsules suppliers

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 24mg capsules (Krka UK Ltd) and Reminyl XL 24mg capsules (Takeda UK Ltd).

Use with caution

Luventa XL 8mg capsules (Fontus Health Ltd)

Explore other Galantamine formulations Explore other Galantamine 8mg modified-release capsules suppliers

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 8mg capsules (Krka UK Ltd) and Reminyl XL 8mg capsules (Takeda UK Ltd).

No Stability Information

Lyclear 1% creme rinse (Omega Pharma Ltd)

Explore other Permethrin formulations Explore other Permethrin 1% scalp application suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Lyclear lotion (Omega Pharma Ltd)

Explore other Dimeticone formulations Explore other Dimeticone 4% lotion suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Lycopodium clavatum 30c homeopathic tablets (Weleda (UK) Ltd)

Explore other Homeopathic lycopodium clavatum formulations Explore other Lycopodium clavatum 30c homeopathic tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Lyfnua 45mg tablets (Merck Sharp & Dohme (UK) Ltd)

Explore other Gefapixant formulations Explore other Gefapixant 45mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Lymecycline 408mg capsules (A A H Pharmaceuticals Ltd)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Use with caution

Lymecycline 408mg capsules (AAH Hillcross)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Use with caution

Lymecycline 408mg capsules (Alliance Healthcare (Distribution) Ltd)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Use with caution

Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Use with caution

Lymecycline 408mg capsules (Medihealth (Northern) Ltd)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Use with caution

Lymecycline 408mg capsules (Morningside Healthcare Ltd)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Use with caution

Lymecycline 408mg capsules (Sigma Pharmaceuticals Plc)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Use with caution

Lymecycline 408mg capsules (Somex Pharma)

Explore other Lymecycline formulations Explore other Lymecycline 408mg capsules suppliers

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.